GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G&E Healthcare Co Ltd (XKRX:299480) » Definitions » Equity-to-Asset

G&E Healthcare Co (XKRX:299480) Equity-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is G&E Healthcare Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. G&E Healthcare Co's Total Stockholders Equity for the quarter that ended in . 20 was ₩0.00 Mil. G&E Healthcare Co's Total Assets for the quarter that ended in . 20 was ₩0.00 Mil.

The historical rank and industry rank for G&E Healthcare Co's Equity-to-Asset or its related term are showing as below:

XKRX:299480's Equity-to-Asset is not ranked *
in the Biotechnology industry.
Industry Median: 0.67
* Ranked among companies with meaningful Equity-to-Asset only.

G&E Healthcare Co Equity-to-Asset Historical Data

The historical data trend for G&E Healthcare Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G&E Healthcare Co Equity-to-Asset Chart

G&E Healthcare Co Annual Data
Trend
Equity-to-Asset

G&E Healthcare Co Semi-Annual Data
Equity-to-Asset

Competitive Comparison of G&E Healthcare Co's Equity-to-Asset

For the Biotechnology subindustry, G&E Healthcare Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G&E Healthcare Co's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G&E Healthcare Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where G&E Healthcare Co's Equity-to-Asset falls into.



G&E Healthcare Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

G&E Healthcare Co's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )=Total Stockholders Equity/Total Assets
=/
=

G&E Healthcare Co's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )=Total Stockholders Equity/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G&E Healthcare Co  (XKRX:299480) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


G&E Healthcare Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of G&E Healthcare Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


G&E Healthcare Co (XKRX:299480) Business Description

Traded in Other Exchanges
N/A
Address
No. 92, Keji 5th Road, Annan District, Tainan, TWN, 70955
G&E Healthcare Co Ltd, formerly G&E Biotech Co Ltd is a biopharmaceutical company focused on the development and commercialization of novel botanical extraction technology and products. It offers a range of products that include Hepato Protective Agent (Hepanamin) which prevent and cure for acute and chronic hepatitis, fatty liver conditions and liver toxicity infections, Botanical Healthcare product, and Botanical Anti-aging cosmetics.

G&E Healthcare Co (XKRX:299480) Headlines

No Headlines